124I-PEG-AVP0458

N/A

Report date: 2025/10/20 14:38:46

NME

Base Information

Drug Name124I-PEG-AVP0458

Drug Alias NameN/A

ClassificationRadiation-emitting products > Nuclides > Iodine > 124IRadiation-emitting products > Radioactive diagnostic agentRadiation-emitting products > Radionuclide Drug Conjugates

Mechanisms of ActionTumor-associated glycoprotein 72 binders

TargetsTumor-associated glycoprotein 72

Therapy Area/IndicationsProstatic NeoplasmsOvarian Neoplasms

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryAustralia

CombinationsNo

Global Highest StatusPhase 1 Clinical

Highest Status in ChinaN/A

Originator CompaniesAvipep

China Registration ClassN/A

Develop Information

Active CompaniesAvipep

Inactive CompaniesN/A

Active IndicationsProstatic NeoplasmsOvarian Neoplasms

Inactive IndicationsN/A

Other Information

ATC CodeN/A